IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

Nature Immunology

Volumn 8, Issue 4, 2007, Pages 369-377

  Khader, Shabaana A ^a   Bell, Guy K ^a   Pearl, John E ^a   Fountain, Jeffrey J ^a   Rangel Moreno, Javier ^a   Cilley, Garth E ^a   Shen, Fang ^b   Eaton, Sheri M ^a   Gaffen, Sarah L ^b   Swain, Susan L ^a   Locksley, Richard M ^c   Haynes, Laura ^a   Randall, Troy D ^a   Cooper, Andrea M ^a  

^a TRUDEAU INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 23;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CD4+ T LYMPHOCYTE; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; HOST RESISTANCE; INFECTION RESISTANCE; INTERFERON PRODUCTION; LYMPHOCYTE FUNCTION; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; INTERLEUKIN-23; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 34248562792     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1449     Document Type: Article

References (56)

1. Corbett, E.L. et al. The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163, 1009-1021 (2003).
2. Nabeshima, S. et al. Kinetic analysis of Mycobacterium tuberculosis-specific cytokine production by PBMC in adults after BCG vaccination. J. Infect. Chemother. 11, 18-23 (2005).
3. Colditz, G.A. et al. Efficacy of BCG vaccine in the prevention of tuberculosis. J. Am. Med. Assoc. 271, 698-702 (1994).
4. Cooper, A.M., Callahan, J.E., Keen, M., Belisle, J.T. & Orme, I.M. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. Tuber. Lung Dis. 78, 67-73 (1997).
5. Jung, Y.J., Ryan, L., Lacourse, R. & North, R. Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 201, 1915-1924 (2005).
6. Flynn, J.L. & Chan, J. Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93-129 (2001).
7. Alkahoshi, M. et al. Influence of interleukin-12 receptor β1 polymorphisms on tuberculosis. Hum. Genet. 112, 237-243 (2003).
8. Tso, H.W., Lau, Y.L., Tam, C.M., Wong, H.S. & Chiang, A.K. Associations between IL12β polymorphisms and tuberculosis in the Hong Kong chinese population. J. Infect. Dis. 190, 913-919 (2004).
9. Cooper, A.M., Magram, J., Ferrante, J. & Orme, I.M. IL-12 is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186, 39-46 (1997).
10. Holscher, C. et al. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167, 6957-6966 (2001).
11. Cooper, A.M. et al. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 168, 1322-1327 (2002).
12. Leal, I.S., Smedegard, B., Andersen, P. & Appelberg, R. Interleukin-6 and interleukin-12 participate in induction at a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine. Infect. Immun. 67, 5747-5754 (1999).
13. Stobie, L. et al. The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/ effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc. Natl. Acad. Sci. USA 97, 8427-8432 (2000).
14. Khader, S.A. et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J. Immunol. 175, 788-795 (2005).
15. Cruz, A. et al. CE:IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection1. J. Immunol. 177, 1416-1420 (2006).
16. Veldhoen, M., Hocking, R., Atkins, C., Locksley, R. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 (2006).
17. H17 lineage. Nature 441, 231-234 (2006).
18. H17 and regulatory T cells. Nature 441, 235-238 (2006).
19. Aggarwal, S. & Gurney, A.L. IL-17: Prototype member of an emerging cytokine family. J. Leukoc. Biol. 71, 1-8 (2002).
20. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 (2005).
21. Nakae, S., Nambu, A., Sudo, K. & Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173-6177 (2003).
22. Nakae, S. et al. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 100, 5986-5990 (2003).
23. Fossiez, F. et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 193, 2593-2603 (1996).
24. Jones, C.E. & Chan, K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-α, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 26, 748-753 (2002).
25. Ye, P. et al. Requirement of Interleukin-17 receptor signalling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recriutment, and host defense. J. Exp. Med. 194, 519-527 (2001).
26. Kolls, J.K., Kanaly, S.T. & Ramsay, A.J. Interleukin-17: An emerging role in lung inflammation. Am. J. Respir. Cell Mol. Biol. 28 9-11 (2003).
27. Moseley, T.A., Haudenschild, D., Rose, L. & Reddi, A. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14, 155-174 (2003).
28. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
29. + effector T cells develop via a lineage distinct from the T helper 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005).
30. Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715-725 (2000).
31. Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699-5708 (2002).
32. Aggarwal, S., Ghilardi, N., Xie, M-H., deSauvage, F. & Gurney, A. Interleukin 23 promotes a distinct CD4 T cell activation state characterized by the production of IL-17. J. Biol. Chem. 278 1910-1914 (2003).
33. Winslow, G.M., Roberts, A.D., Blackman, M.A. & Woodland, D.L. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J. Immunol. 170, 2046-2052 (2003).
34. Evans, J. et al. Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529. Expert Rev. Vaccines 2 219-229 (2003).
35. Geisel, R.E., Sakamoto, K., Russell, D. & Rhoades, E. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to trehalose mycolates. J. Immunol. 174, 5007-5015 (2005).
36. Kim, C.H. & Broxmeyer, H.E. Chemokines: Signal lamps for trafficking of T and B cells for development and effector function. J. Leukoc. Biol. 65, 6-15 (1999).
37. MacMicking, J.D., Taylor, G. & McKinney, J. Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science 302, 654-659 (2003).
38. Shen, F., Hu, Z., Goswami, J. & Gaffen, S. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J. Biol. Chem. 281, 24138-24148 (2006).
39. Reinhardt, R.L., Hong, S., Kang, S., Wang, Z. & Locksley, R. Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation. J. Immunol. 177, 1618-1627 (2006).
40. Wozniak, T.M., Ryan, A. & Britton, W. Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J. Immunol. 177, 8684-8692 (2006).
41. Veldhoen, M., Hocking, R., Flavell, R. & Stockinger, B. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7, 1151-1156 (2006).
42. Belladonna, M.L. et al. IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J. Immunol. 168 5448-5454 (2002).
43. Higgins, S.C., Jamicki, A., Lavelle, E. & Mills, K. TLR4 Mediates vaccine-induced protective cellular immunity to Bordetella pertussis role of IL-17-producing T cells. J. Immunol. 177, 7980-7989 (2006).
44. Baekkevold, E.S. et al. A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations. J. Exp. Med. 201, 1045-1051 (2005).
45. Byersdorfer, C.A. & Chaplin, D. Visualization of early APC/T cell interactions in the mouse lung following intranasal challenge. J. Immunol. 167, 6756-6764 (2001).
46. Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467-476 (2004).
47. Miyamoto, M. et al. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J. Immunol. 170, 4665-4672 (2003).
48. Appelberg, R. Neutrophils and intracellular pathogens: Beyond phagocytosis and killing. Trends Microbiol. 15, 87-92 (2007).
49. Chackerian, A.A. et al. Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection. Infect. Immun. 74, 6092-6099 (2006).
50. Gaffen, S.L. Biology of recently discovered cytokines: Interleukin-17-a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Res. Ther. 6, 240-247 (2004).
51. Ghilardi, N. et al. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J. Immunol. 172: 2827-2833 (2004).
52. Khader, S.A. et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 203, 1805-1815 (2006).
53. Olsen, A.W., Hansen, P., Holm, A. & Andersen, P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single immunodominant epitope from the ESAT-6 antigen. Eur. J. Immunol. 30, 1724-1732 (2000).
54. Happel, K.I. et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202, 761-769 (2005).
55. Hollenbaugh, J.A. & Dutton, R. IFN-γ regulates donor CD8 T cell expansion, migration and leads to solid tumor apoptosis. J. Immunol. 177, 3004-3011 (2006).
56. Flano, E., Kayhan, B., Woodland, D. & Blackman, M. Infection of dendritic cells by a γ2-herpesvirus induces functional modulation. J. Immunol. 175, 3225-3234 (2005).